Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.69% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BGRY
4001
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $67.8K | ﹤0.01% |
112,350
| – | – |
|
|
MITT
4002
TPG Mortgage Investment Trust
MITT
$214M
| $67.7K | ﹤0.01% |
12,747
-20,420
| -62% | -$105K |
|
|
IRNT
4003
DELISTED
IronNet, Inc.
IRNT
| $67K | ﹤0.01% |
291,233
+83,936
| +40% | +$41.9K |
|
4004
Alaunos Therapeutics
TCRT
$4.86M
| $66.6K | ﹤0.01% |
684
| – | – |
|
4005
Vroom Inc
VRM
$54M
| $66.4K | ﹤0.01% |
813
| – | – |
|
4006
Orion Energy Systems
OESX
$78.9M
| $66K | ﹤0.01% |
3,624
-6,029
| -62% | -$112K |
|
|
AGIL
4007
DELISTED
AgileThought Inc
AGIL
| $64.9K | ﹤0.01% |
15,458
| – | – |
|
|
RBT
4008
DELISTED
Rubicon Technologies, Inc.
RBT
| $64.7K | ﹤0.01% |
4,546
| – | – |
|
4009
Zevia
ZVIA
$101M
| $64.6K | ﹤0.01% |
15,785
-1
| -0% | -$4 |
|
|
KG
4010
Kestrel Group
KG
$60.5M
| $64.5K | ﹤0.01% |
1,529
| – | – |
|
4011
CEL-SCI Corp
CVM
$26M
| $64.2K | ﹤0.01% |
911
-9
| -1% | -$792 |
|
4012
Harmony Gold Mining
HMY
$12B
| $63.4K | ﹤0.01% |
18,660
-3,056
| -14% | -$9.64K |
|
4013
SCYNEXIS
SCYX
$50.9M
| $63.3K | ﹤0.01% |
5,070
| – | – |
|
4014
Omeros
OMER
$1.26B
| $63.2K | ﹤0.01% |
27,950
| – | – |
|
4015
Gaia
GAIA
$33.3M
| $63K | ﹤0.01% |
26,490
-23,712
| -47% | -$58.6K |
|
4016
LifeMD
LFMD
$167M
| $63K | ﹤0.01% |
32,475
-202
| -0.6% | -$453 |
|
4017
Mistras Group
MG
$584M
| $62.6K | ﹤0.01% |
12,700
-21,012
| -62% | -$95.2K |
|
4018
OppFi
OPFI
$608M
| $62K | ﹤0.01% |
30,259
| – | – |
|
|
ATXI
4019
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $61.9K | ﹤0.01% |
+712
| New | +$129K |
|
|
RVPH
4020
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $61.8K | ﹤0.01% |
+727
| New | +$55.4K |
|
|
KBNT
4021
DELISTED
Kubient, Inc. Common Stock
KBNT
| $61.5K | ﹤0.01% |
96,145
-751
| -0.8% | -$731 |
|
|
AGFS
4022
DELISTED
AgroFresh Solutions Inc
AGFS
| $61.4K | ﹤0.01% |
20,748
| – | – |
|
4023
Dave Inc
DAVE
$4.26B
| $61.4K | ﹤0.01% |
6,613
-34
| -0.5% | -$363 |
|
4024
Korro Bio
KRRO
$196M
| $61.3K | ﹤0.01% |
319
| – | – |
|
4025
Cue Biopharma
CUE
$131M
| $60.7K | ﹤0.01% |
710
-1
| -0.1% | -$91 |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.